TY  - ADVS
AU  - Rossing,Peter
TI  - Proteomics in kidney disease: clinical considerations 
T2  - Clinical proteomics,
PY  - 2013///
CY  - London
PB  - Henry Stewart Talks
KW  - Biochemical markers
KW  - Kidneys
KW  - Diseases
KW  - Proteomics
KW  - Methodology
KW  - Biomarkers
KW  - Kidney Diseases
KW  - Proteome
KW  - analysis
KW  - methods
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Proteomics for clinical use -- Available and applied single risk marker strategies in nephrology based on hypothesis driven biomarker search -- Open or unbiased multimarker approaches including plasma and urine proteomics -- Examples from different renal diseases -- Data from cross sectional and longitudinal studies -- Proteomics may provide insight into disease pathology -- Proteomics may provide risk stratification for clinical trials -- Example: intervention trial for type 2 diabetic subjects with high risk urinary proteomic pattern; Access restricted to subscribers
UR  - https://hstalks.com/bs/2656/
UR  - https://hstalks.com/bs/p/751/
UR  - https://hstalks.com/bs/p/980/
ER  -